We are live on ! Find out more
EDIT icon

Editas Medicine
EDIT

75 hedge funds and large institutions have $300M invested in Editas Medicine in 2016 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 23 increasing their positions, 15 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 15

53% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 15

10% more funds holding

Funds holding: 68 → 75 (+7)

0% more funds holding in top 10

Funds holding in top 10: 5 → 5 (0)

45% less capital invested

Capital invested by funds: $550M → $300M (-$250M)

63% less call options, than puts

Call options by funds: $44K | Put options by funds: $120K

Holders
75
Holders Change
+7
Holders Change %
+10.29%
% of All Funds
2%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.13%
New
24
Increased
23
Reduced
15
Closed
15
Calls
$44K
Puts
$120K
Net Calls
-$76K
Net Calls Change
-$76K

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
+$14.7M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$9.43M
3
SM
Sabby Management
Florida
+$2.77M
4
Renaissance Technologies
Renaissance Technologies
New York
+$2.17M
5
BIT
BlackRock Institutional Trust
California
+$2.15M

Top Sellers

1
PVMCV
Polaris Venture Management Co VI
Massachusetts
-$10.2M
2
AI
Alphabet Inc
California
-$6.26M
3
Jennison Associates
Jennison Associates
New York
-$4.13M
4
EC
EcoR1 Capital
California
-$2.08M
5
Morgan Stanley
Morgan Stanley
New York
-$945K
Name Holding Trade Value Shares
Change 		Change in
Stake
Jennison Associates
76
Jennison Associates
New York
– -$4.13M -170,940 Closed
EC
77
EcoR1 Capital
California
– -$2.08M -85,469 Closed
Squarepoint
78
Squarepoint
New York
– -$376K -15,400 Closed
SG Americas Securities
79
SG Americas Securities
New York
– -$356K -14,597 Closed
SIM
80
Spark Investment Management
New York
– -$326K -13,400 Closed
PP
81
Paloma Partners
Connecticut
– -$252K -10,333 Closed
CIM
82
CIM Investment Management
Pennsylvania
– -$229K -9,366 Closed
MLICM
83
Metropolitan Life Insurance Company (MetLife)
New York
– -$181K -7,426 Closed
Creative Planning
84
Creative Planning
Kansas
– -$32.8K -1,600 -100%
Teacher Retirement System of Texas
85
Teacher Retirement System of Texas
Texas
– -$24K -998 Closed
TRCT
86
Tower Research Capital (TRC)
New York
– -$16K -647 Closed
NSIM
87
North Star Investment Management
Illinois
– -$5K -200 Closed
CCA
88
Catalyst Capital Advisors
New York
– -$3K -130 Closed
PNC Financial Services Group
89
PNC Financial Services Group
Pennsylvania
– -$1K -59 Closed
ECM
90
Exchange Capital Management
Michigan
– -$1K -25 Closed
1 2 3
4

EDIT Hedge Fund Activity: Q3 2016 in Review

75 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q3 2016, worth a combined $300M — down 45% from $550M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new EDIT positions and 15 closed out — a net gain of 9 holders — while 23 added to existing stakes and 15 trimmed.

The largest buyer was Vanguard Group, adding an estimated $14.7M. The largest seller was Polaris Venture Management Co VI, cutting an estimated $10.2M.

  • 75 institutional investors held Editas Medicine (EDIT) as of Q3 2016, up from 68 in Q2 2016.
  • Funds reported $300M of Editas Medicine stock for Q3 2016, down 45% quarter-over-quarter.
  • 24 funds opened new Editas Medicine positions in Q3 2016 and 15 closed out, a net change of +9 holders.
  • The largest Editas Medicine buyer in Q3 2016 was Vanguard Group, an estimated $14.7M added.
  • The largest Editas Medicine seller in Q3 2016 was Polaris Venture Management Co VI, an estimated $10.2M sold.

Based on aggregated 13F filings for Q3 2016.